Latest Breaking News On - Karin eastham - Page 2 : comparemela.com

Veracyte (NASDAQ:VCYT) Issues Earnings Results, Beats Expectations By $0 17 EPS

Veracyte (NASDAQ:VCYT) Issues Earnings Results, Beats Expectations By $0 17 EPS
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairKarin easthamVeracyte incGoldman sachs groupMorgan stanleyNeedham companySecurities exchange commissionGet free reportDirector karin easthamExchange commissionAfirma genomic sequencing classifierDecipher prostate biopsyRadical prostatectomyProsigna breast cancer assayPercepta nasal swab test

Veracyte (NASDAQ:VCYT) Posts Earnings Results

Veracyte (NASDAQ:VCYT) Posts Earnings Results
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairKarin easthamVeracyte incNeedham companyMorgan stanleyGoldman sachs groupGet free reportDirector karin easthamAfirma genomic sequencing classifierDecipher prostate biopsyRadical prostatectomyProsigna breast cancer assayPercepta nasal swab testEnvisia genomic classifierVeracyte daily

Veracyte (VCYT) Scheduled to Post Quarterly Earnings on Tuesday

Veracyte (NASDAQ:VCYT – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of ($0.19) per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link. Veracyte (NASDAQ:VCYT – Get […]

United statesKarin easthamWilliam blairSecurities exchange commissionMorgan stanleyGoldman sachs groupVeracyte incNeedham companyVeracyte company profileGet free reportTrading downDirector karin easthamExchange commissionAfirma genomic sequencing classifierDecipher prostate biopsyRadical prostatectomy

Sumitomo Mitsui Trust Holdings Inc Cuts Position in Veracyte, Inc (NASDAQ:VCYT)

Sumitomo Mitsui Trust Holdings Inc. cut its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 2.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,104,676 shares of the biotechnology company’s stock after selling 68,900 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned about […]

United statesWilliam blairKarin easthamMorgan stanleyInvestment managementVeracyte incNeedham companyInvesco ltdBlackrock incSumitomo mitsui trust holdings incSecurities exchange commissionVanguard group incGoldman sachs groupSumitomo mitsui trust holdingsFree reportMitsui trust holdings

Dr Kenneth J Widder Joins Personalis Board of Directors

Personalis, Inc. today announced that it has appointed Kenneth J. Widder, M.D., to its Board of Directors. Dr. Widder currently serves on the boards of QuidelOrtho Corporation and Evoke Pharma,. | June 13, 2023

United statesAlan colowickKarin easthamKennethj widderNovacardia incMolecular biosystems incNorthwestern universityDuke universitySytera incQuidelortho corporationSantarus incPersonalis incPharma incOrphomed incSydnexis incEvoke pharma